JK Pharmachem Ltd. - Research Center
500218 JKPHARMA Group (XD) BSE data
Results
Statement
More
Sep ' 05 |
Sep ' 04 |
Sep ' 03 |
Sep ' 02 |
Sep ' 01 |
Equity share capital
62.68 |
62.68 |
62.68 |
62.68 |
62.68 |
Share application money
Preference share capital
31.32 |
31.32 |
31.32 |
31.32 |
31.32 |
Reserves & surplus
-100.10 |
-87.62 |
-50.24 |
-44.60 |
-55.44 |
Secured loans
105.23 |
99.68 |
92.01 |
94.72 |
99.18 |
Unsecured loans
Total
104.98 |
113.11 |
143.84 |
152.24 |
145.40 |
Gross block
191.80 |
192.49 |
191.66 |
190.51 |
189.51 |
Less : revaluation reserve
Less : accumulated depreciation
85.64 |
85.65 |
75.77 |
66.17 |
56.44 |
Net block
106.17 |
106.84 |
115.89 |
124.34 |
133.07 |
Capital work-in-progress
Investments
Current assets, loans & advances
6.27 |
17.16 |
58.58 |
38.54 |
24.82 |
Less : current liabilities & provisions
7.57 |
11.35 |
31.55 |
12.11 |
16.66 |
Total net current assets
-1.30 |
5.81 |
27.03 |
26.43 |
8.16 |
Miscellaneous expenses not written
Total
104.98 |
113.11 |
143.84 |
152.24 |
145.40 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
0.92 |
20.72 |
20.55 |
21.99 |
21.87 |
Number of equity sharesoutstanding (Lacs)
626.85 |
626.85 |
626.85 |
626.85 |
626.85 |